Skip to main content
main-content
Erschienen in: InFo Neurologie + Psychiatrie 1/2022

19.01.2022 | COVID-19 | Zertifizierte Fortbildung Neurologie Zur Zeit gratis

Pandemie

Neurologische Nebenwirkungen der COVID-19-Impfung

verfasst von: Prof. Dr. med. Hans-Christoph Diener, Prof. Dr. med. Peter Berlit, Prof. Dr. med. Christian Gerloff, Prof. Dr. med. Dagny Holle-Lee, Prof. Dr. med. Tobias Kurth, ScD Tobias Kurth, Prof. Dr. med. Jörg B. Schulz

Erschienen in: InFo Neurologie + Psychiatrie | Ausgabe 1/2022

zum CME-Kurs Einloggen, um Zugang zu erhalten

Auszug

Nach einer Impfung gegen COVID-19 kann es in extrem seltenen Fällen zu neurologischen Komplikationen kommen. Ein ursächlicher Zusammenhang ist belegt zwischen der Anwendung von Vektorimpfstoffen und der Auslösung einer immuninduzierten thrombotischen Thrombozytopenie mit Sinus- und Hirnvenenthrombosen. Weitere mögliche neurologische Komplikationen nach COVID-19-Impfung mit Vektorimpfstoffen sind ischämische Hirninfarkte und Hirnblutungen, das Guillain-Barré-Syndrom, Fazialisparesen und Enzephalomyelitiden. Nach mRNA-Impfstoffen kann es in seltenen Fällen zu einer Myokarditis, einer Perikarditis oder zu Fazialisparesen kommen.
Literatur
1.
Zurück zum Zitat Klein NP, Lewis N, Goddard K, Fireman B, Zerbo O, Hanson KE et al. Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA 2021 Oct 12;326(14):1390-99 Klein NP, Lewis N, Goddard K, Fireman B, Zerbo O, Hanson KE et al. Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA 2021 Oct 12;326(14):1390-99
2.
Zurück zum Zitat Pottegård A, Lund LC, Karlstad Ø, Dahl J, Andersen M, Hallas J, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ 2021;373:n1114. Pottegård A, Lund LC, Karlstad Ø, Dahl J, Andersen M, Hallas J, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ 2021;373:n1114.
3.
Zurück zum Zitat Schultz NH, Sorvoll IH, Michelsen AE et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021 Jun 3;384(22):2124-30 Schultz NH, Sorvoll IH, Michelsen AE et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021 Jun 3;384(22):2124-30
4.
Zurück zum Zitat See I, Su JR, Lale A, Woo EJ, Guh AY, Shimabukuro TT et al. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021. JAMA 2021;325(24):2448-56 See I, Su JR, Lale A, Woo EJ, Guh AY, Shimabukuro TT et al. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021. JAMA 2021;325(24):2448-56
5.
Zurück zum Zitat Schulz JB, Berlit P, Diener HC, Gerloff C, Greinacher A, Klein C et al. COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany. Ann Neurol 2021;90(4):627-39 Schulz JB, Berlit P, Diener HC, Gerloff C, Greinacher A, Klein C et al. COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany. Ann Neurol 2021;90(4):627-39
6.
Zurück zum Zitat Bikdeli B, Chatterjee S, Arora S et al. Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19. J Am Coll Cardiol 2021;78(4):408-11 Bikdeli B, Chatterjee S, Arora S et al. Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19. J Am Coll Cardiol 2021;78(4):408-11
7.
Zurück zum Zitat Siegler JE, Klein P, Yaghi S et al. Cerebral Vein Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia. Stroke 2021;52(9):3045-53 Siegler JE, Klein P, Yaghi S et al. Cerebral Vein Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia. Stroke 2021;52(9):3045-53
8.
Zurück zum Zitat Taquet M, Husain M, Geddes JR, Luciano S, Harrison PJ. Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases. EClinicalMedicine 2021;39:101061 Taquet M, Husain M, Geddes JR, Luciano S, Harrison PJ. Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases. EClinicalMedicine 2021;39:101061
10.
Zurück zum Zitat Taquet M, Husain M, Geddes J, Luciano S, Harrison P. COVID-19 and Cerebral Venous Thrombosis: A Retrospective Cohort Study of 513,284 Confirmed COVID-19 Cases. OSF April 26 doi:1017605/OSFIO/H2MT7. 2021. Taquet M, Husain M, Geddes J, Luciano S, Harrison P. COVID-19 and Cerebral Venous Thrombosis: A Retrospective Cohort Study of 513,284 Confirmed COVID-19 Cases. OSF April 26 doi:1017605/OSFIO/H2MT7. 2021.
11.
Zurück zum Zitat Ropper AH, Klein JP. Cerebral Venous Thrombosis. New England Journal of Medicine 2021;385(1):59-64 Ropper AH, Klein JP. Cerebral Venous Thrombosis. New England Journal of Medicine 2021;385(1):59-64
12.
Zurück zum Zitat Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A et al. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. J Neurol Sci 2021;428:117607. Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A et al. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. J Neurol Sci 2021;428:117607.
13.
Zurück zum Zitat Perry RJ, Tamborska A, Singh B, Craven B, Marigold R, Arthur-Farraj P, et al. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. 2021. Lancet 2021;398(10306):1147-56 Perry RJ, Tamborska A, Singh B, Craven B, Marigold R, Arthur-Farraj P, et al. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. 2021. Lancet 2021;398(10306):1147-56
14.
Zurück zum Zitat Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021; 384:2092-101 Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021; 384:2092-101
15.
Zurück zum Zitat Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M et al. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021;384:2202-11 Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M et al. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021;384:2202-11
16.
Zurück zum Zitat Thiele T, Ulm L, Holtfreter S, Schönborn L, Kuhn SO, Scheer C et al. Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2. 2021 Blood 2021 Jul 29;138(4):299-303 Thiele T, Ulm L, Holtfreter S, Schönborn L, Kuhn SO, Scheer C et al. Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2. 2021 Blood 2021 Jul 29;138(4):299-303
17.
Zurück zum Zitat Althaus K, Möller P, Uzun G, Singh A, Beck A, Bettag M, et al. Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica 2021;106(8):2170-79 Althaus K, Möller P, Uzun G, Singh A, Beck A, Bettag M, et al. Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica 2021;106(8):2170-79
18.
Zurück zum Zitat FACME ad-hoc Expert Working Group. Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination. Neurologia (Engl Ed) 2021;36(6):451-61 FACME ad-hoc Expert Working Group. Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination. Neurologia (Engl Ed) 2021;36(6):451-61
20.
Zurück zum Zitat Graf T, Thiele T, Klingebiel R et al. Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19- adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis. J Neurol 2021 ;268(12):4483-5 Graf T, Thiele T, Klingebiel R et al. Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19- adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis. J Neurol 2021 ;268(12):4483-5
21.
Zurück zum Zitat Bourguignon A, Arnold DM, Warkentin TE et al. Adjunct Immune Globulin for Vaccine-Induced Thrombotic Thrombocytopenia. N Engl J Med 2021 Aug 19;385(8):720-8 Bourguignon A, Arnold DM, Warkentin TE et al. Adjunct Immune Globulin for Vaccine-Induced Thrombotic Thrombocytopenia. N Engl J Med 2021 Aug 19;385(8):720-8
22.
Zurück zum Zitat Patriquin CJ, Laroche V, Selby R et al. Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med 2021;385(9):857-9 Patriquin CJ, Laroche V, Selby R et al. Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med 2021;385(9):857-9
23.
Zurück zum Zitat Rizk JG, Gupta A, Sardar P, Henry BM, Lewin JC, Lippi G et al. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA Cardiol 2021 Aug 10. doi: 10.1001/jamacardio.2021.3444. Rizk JG, Gupta A, Sardar P, Henry BM, Lewin JC, Lippi G et al. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA Cardiol 2021 Aug 10. doi: 10.1001/jamacardio.2021.3444.
24.
Zurück zum Zitat Schulz JB, Berlit P, Diener HC, Gerloff C, Greinacher A, Klein C, et al. COVID-19 vaccine-associated cerebral venous thrombosis in Germany. Ann Neurol 2021 Oct;90(4):627-39 Schulz JB, Berlit P, Diener HC, Gerloff C, Greinacher A, Klein C, et al. COVID-19 vaccine-associated cerebral venous thrombosis in Germany. Ann Neurol 2021 Oct;90(4):627-39
25.
Zurück zum Zitat Bjørnstad-Tuveng TH, Rudjord A, Anker P. Fatal cerebral haemorrhage after COVID-19 vaccine. Tidsskr Nor Laegeforen 2021;141. Bjørnstad-Tuveng TH, Rudjord A, Anker P. Fatal cerebral haemorrhage after COVID-19 vaccine. Tidsskr Nor Laegeforen 2021;141.
26.
Zurück zum Zitat Kenda J, Lovrič D, Škerget M, Milivojević N. Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2021;30(11):106072. Kenda J, Lovrič D, Škerget M, Milivojević N. Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2021;30(11):106072.
27.
Zurück zum Zitat Costentin G, Ozkul-Wermester O, Triquenot A, Cam-Duchez VL, Massy N, Benhamou Y et al. Acute Ischemic Stroke Revealing ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy. J Stroke Cerebrovasc Dis 2021 Sep;30(9):105942. Costentin G, Ozkul-Wermester O, Triquenot A, Cam-Duchez VL, Massy N, Benhamou Y et al. Acute Ischemic Stroke Revealing ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy. J Stroke Cerebrovasc Dis 2021 Sep;30(9):105942.
28.
Zurück zum Zitat Blauenfeldt RA, Kristensen SR, Ernstsen SL, Kristensen CCH, Simonsen CZ, Hvas AM. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine. J Thromb Haemost 2021;19(7):1771-5 Blauenfeldt RA, Kristensen SR, Ernstsen SL, Kristensen CCH, Simonsen CZ, Hvas AM. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine. J Thromb Haemost 2021;19(7):1771-5
29.
Zurück zum Zitat Bayas A, Menacher M, Christ M, Behrens L, Rank A, Naumann M. Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Lancet (London, England) 2021;397(10285):e11-e. Bayas A, Menacher M, Christ M, Behrens L, Rank A, Naumann M. Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Lancet (London, England) 2021;397(10285):e11-e.
30.
Zurück zum Zitat Li X, Ostropolets A, Makadia R, Shoaibi A, Rao G, Sena AG et al. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ 2021;373:n1435. Li X, Ostropolets A, Makadia R, Shoaibi A, Rao G, Sena AG et al. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ 2021;373:n1435.
31.
Zurück zum Zitat Nachamkin I, Shadomy SV, Moran AP et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis 2008;198(2):226-33 Nachamkin I, Shadomy SV, Moran AP et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis 2008;198(2):226-33
32.
Zurück zum Zitat Salmon DA, Vellozzi C, Chen RT, Halsey NA. Did the influenza A (H1N1) 2009 monovalent inactivated vaccines increase the risk for Guillain-Barré syndrome? Expert Rev Clin Immunol 2013;9(9):795-7 Salmon DA, Vellozzi C, Chen RT, Halsey NA. Did the influenza A (H1N1) 2009 monovalent inactivated vaccines increase the risk for Guillain-Barré syndrome? Expert Rev Clin Immunol 2013;9(9):795-7
33.
Zurück zum Zitat Luo G, Ambati A, Lin L, Bonvalet M, Partinen M, Ji X et al. Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy. Proc Natl Acad Sci U S A 2018;115(52):E12323-e32. Luo G, Ambati A, Lin L, Bonvalet M, Partinen M, Ji X et al. Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy. Proc Natl Acad Sci U S A 2018;115(52):E12323-e32.
34.
Zurück zum Zitat Petráš M, Lesná IK, Dáňová J, Čelko AM. Is an Increased Risk of Developing Guillain-Barré Syndrome Associated with Seasonal Influenza Vaccination? A Systematic Review and Meta-Analysis. Vaccines (Basel) 2020;8(2):150 Petráš M, Lesná IK, Dáňová J, Čelko AM. Is an Increased Risk of Developing Guillain-Barré Syndrome Associated with Seasonal Influenza Vaccination? A Systematic Review and Meta-Analysis. Vaccines (Basel) 2020;8(2):150
35.
Zurück zum Zitat Li X, Ostropolets A, Makadia R, Shaoibi A, Rao G, Sena AG, et al. Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study. medRxiv 2021 Apr 17;2021.03.25.21254315. Li X, Ostropolets A, Makadia R, Shaoibi A, Rao G, Sena AG, et al. Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study. medRxiv 2021 Apr 17;2021.03.25.21254315.
36.
Zurück zum Zitat Berlit P, Lehmann H. Vorsicht vor kausalen Verknüpfungen. DGNeurologie 2021;4(3):149-50 Berlit P, Lehmann H. Vorsicht vor kausalen Verknüpfungen. DGNeurologie 2021;4(3):149-50
37.
Zurück zum Zitat Márquez Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Guillain- Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality. Neurology 2021 Apr 6;10.1212/WNL.0000000000011881. Márquez Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Guillain- Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality. Neurology 2021 Apr 6;10.1212/WNL.0000000000011881.
38.
Zurück zum Zitat Maramattom BV, Krishnan P, Paul R, Padmanabhan S, Cherukudal Vishnu Nampoothiri S, Syed AA et al. Guillain-Barré Syndrome following ChAdOx1-S/nCoV-19 Vaccine. Ann Neurol 2021;90(2):312-4 Maramattom BV, Krishnan P, Paul R, Padmanabhan S, Cherukudal Vishnu Nampoothiri S, Syed AA et al. Guillain-Barré Syndrome following ChAdOx1-S/nCoV-19 Vaccine. Ann Neurol 2021;90(2):312-4
39.
Zurück zum Zitat Allen CM, Ramsamy S, Tarr AW, Tighe PJ, Irving WL, Tanasescu R et al. Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination. Ann Neurol 2021;90(2):315-8 Allen CM, Ramsamy S, Tarr AW, Tighe PJ, Irving WL, Tanasescu R et al. Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination. Ann Neurol 2021;90(2):315-8
40.
Zurück zum Zitat Woo EJ, Mba-Jonas A, Dimova RB, Alimchandani M, Zinderman CE, Nair N. Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021. JAMA 2021 Oct 26;326(16):1606-13 Woo EJ, Mba-Jonas A, Dimova RB, Alimchandani M, Zinderman CE, Nair N. Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021. JAMA 2021 Oct 26;326(16):1606-13
41.
Zurück zum Zitat Cao L, Ren L. Acute disseminated encephalomyelitis after severe acute respiratory syndrome coronavirus 2 vaccination: a case report. Acta Neurol Belg 2021:1-3 Cao L, Ren L. Acute disseminated encephalomyelitis after severe acute respiratory syndrome coronavirus 2 vaccination: a case report. Acta Neurol Belg 2021:1-3
42.
Zurück zum Zitat Singh Malhotra H, Gupta P, Prabhu V, Garg RK, Dandu H, Agarwal V. COVID-19 vaccination-associated myelitis. QJM 2021 Mar 31;hcab069 Singh Malhotra H, Gupta P, Prabhu V, Garg RK, Dandu H, Agarwal V. COVID-19 vaccination-associated myelitis. QJM 2021 Mar 31;hcab069
43.
Zurück zum Zitat Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021;397(10269):99-111 Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021;397(10269):99-111
44.
Zurück zum Zitat Havla J, Schultz Y, Zimmermann H et al. First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine. J Neurol 2021:1-4 Havla J, Schultz Y, Zimmermann H et al. First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine. J Neurol 2021:1-4
45.
Zurück zum Zitat Chen S, Fan XR, He S, Zhang JW, Li SJ. Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19. Neurol Sci 2021:1-3 Chen S, Fan XR, He S, Zhang JW, Li SJ. Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19. Neurol Sci 2021:1-3
46.
Zurück zum Zitat Helmchen C, Buttler GM, Markewitz R, Hummel K, Wiendl H, Boppel T. Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2. J Neurol 2021:1-6 Helmchen C, Buttler GM, Markewitz R, Hummel K, Wiendl H, Boppel T. Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2. J Neurol 2021:1-6
47.
Zurück zum Zitat Achiron A, Dolev M, Menascu S, Zohar DN, Dreyer-Alster S, Miron S et al. COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021. Mult Scler 2021;27(6):864-70 Achiron A, Dolev M, Menascu S, Zohar DN, Dreyer-Alster S, Miron S et al. COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021. Mult Scler 2021;27(6):864-70
48.
Zurück zum Zitat Sotoca J, Rodríguez-Álvarez Y. COVID-19-associated acute necrotizing myelitis. Neurol Neuroimmunol Neuroinflamm 2020;7(5):e803 Sotoca J, Rodríguez-Álvarez Y. COVID-19-associated acute necrotizing myelitis. Neurol Neuroimmunol Neuroinflamm 2020;7(5):e803
49.
Zurück zum Zitat Garjani A, Middleton RM, Hunter R, Tuite-Dalton KA, Coles A, Dobson R et al. COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies. Mult Scler Relat Disord 2021;52:102939. Garjani A, Middleton RM, Hunter R, Tuite-Dalton KA, Coles A, Dobson R et al. COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies. Mult Scler Relat Disord 2021;52:102939.
50.
Zurück zum Zitat Ozonoff A, Nanishi E, Levy O. Bell's palsy and SARS-CoV-2 vaccines. Lancet Infect Dis 2021;21(4):450-2 Ozonoff A, Nanishi E, Levy O. Bell's palsy and SARS-CoV-2 vaccines. Lancet Infect Dis 2021;21(4):450-2
51.
Zurück zum Zitat Ozonoff A, Nanishi E, Levy O. Bell's palsy and SARS-CoV-2 vaccines. The Lancet Infectious Diseases 2021;21(4):450-2 Ozonoff A, Nanishi E, Levy O. Bell's palsy and SARS-CoV-2 vaccines. The Lancet Infectious Diseases 2021;21(4):450-2
52.
Zurück zum Zitat Zhou W, Pool V, DeStefano F, Iskander JK, Haber P, Chen RT et al. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. Pharmacoepidemiol Drug Saf 2004;13(8):505-10 Zhou W, Pool V, DeStefano F, Iskander JK, Haber P, Chen RT et al. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. Pharmacoepidemiol Drug Saf 2004;13(8):505-10
53.
Zurück zum Zitat Huang WT, Huang WI, Huang YW, Hsu CW, Chuang JH. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis. Vaccine 2012;30(12):2168-72 Huang WT, Huang WI, Huang YW, Hsu CW, Chuang JH. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis. Vaccine 2012;30(12):2168-72
54.
Zurück zum Zitat Sato K, Mano T, Niimi Y, Toda T, Iwata A, Iwatsubo T. Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database. Int J Infect Dis 2021;111:310-2 Sato K, Mano T, Niimi Y, Toda T, Iwata A, Iwatsubo T. Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database. Int J Infect Dis 2021;111:310-2
55.
Zurück zum Zitat Göbel CH, Heinze A, Karstedt S, Morscheck M, Tashiro L, Cirkel A et al. Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study. Brain Commun 2021;3(3):fcab169. Göbel CH, Heinze A, Karstedt S, Morscheck M, Tashiro L, Cirkel A et al. Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study. Brain Commun 2021;3(3):fcab169.
56.
Zurück zum Zitat Sekiguchi K, Watanabe N, Miyazaki N, Ishizuchi K, Iba C, Tagashira Y et al. Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study. Cephalalgia 2021:3331024211038654. Sekiguchi K, Watanabe N, Miyazaki N, Ishizuchi K, Iba C, Tagashira Y et al. Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study. Cephalalgia 2021:3331024211038654.
57.
Zurück zum Zitat Salih F, Schönborn L, Kohler S, Franke C, Möckel M, Dörner T, et al. Vaccine-Induced Thrombocytopenia with Severe Headache. N Engl J Med 2021 Sep 15;NEJMc2112974. Salih F, Schönborn L, Kohler S, Franke C, Möckel M, Dörner T, et al. Vaccine-Induced Thrombocytopenia with Severe Headache. N Engl J Med 2021 Sep 15;NEJMc2112974.
58.
Zurück zum Zitat Vogel G, Couzin-Frankel J. Israel reports link between rare cases of heart inflamma-tion and COVID-19 vaccination in young men. Science. 2021;online(01.06.2021). Vogel G, Couzin-Frankel J. Israel reports link between rare cases of heart inflamma-tion and COVID-19 vaccination in young men. Science. 2021;online(01.06.2021).
59.
Zurück zum Zitat Diaz GA, Parsons GT, Gering SK, Meier AR, Hutchinson IV, Robicsek A. Myocarditis and Pericarditis After Vaccination for COVID-19. JAMA 2021 Sep 28;326(12):1210-12 Diaz GA, Parsons GT, Gering SK, Meier AR, Hutchinson IV, Robicsek A. Myocarditis and Pericarditis After Vaccination for COVID-19. JAMA 2021 Sep 28;326(12):1210-12
60.
Zurück zum Zitat Westbury CF. Bayes' rule for clinicians: an introduction. Front Psychol 2010;1:192. Westbury CF. Bayes' rule for clinicians: an introduction. Front Psychol 2010;1:192.
61.
Zurück zum Zitat Kuhnert R, Hecker H, Poethko-Müller C, Schlaud M, Vennemann M, Whitaker HJ, et al. A modified self-controlled case series method to examine association between multidose vaccinations and death. Stat Med 2011;30(6):666-77 Kuhnert R, Hecker H, Poethko-Müller C, Schlaud M, Vennemann M, Whitaker HJ, et al. A modified self-controlled case series method to examine association between multidose vaccinations and death. Stat Med 2011;30(6):666-77
Metadaten
Titel
Pandemie
Neurologische Nebenwirkungen der COVID-19-Impfung
verfasst von
Prof. Dr. med. Hans-Christoph Diener
Prof. Dr. med. Peter Berlit
Prof. Dr. med. Christian Gerloff
Prof. Dr. med. Dagny Holle-Lee
Prof. Dr. med. Tobias Kurth, ScD Tobias Kurth
Prof. Dr. med. Jörg B. Schulz
Publikationsdatum
19.01.2022
Verlag
Springer Medizin
Erschienen in
InFo Neurologie + Psychiatrie / Ausgabe 1/2022
Print ISSN: 1437-062X
Elektronische ISSN: 2195-5166
DOI
https://doi.org/10.1007/s15005-021-2149-4

Weitere Artikel der Ausgabe 1/2022

InFo Neurologie + Psychiatrie 1/2022 Zur Ausgabe

Zertifizierte Fortbildung Psychiatrie

Lithium - ein Update

Corona-Update

Die aktuelle Entwicklung im Überblick: Nachrichten, Webinare, Übersichtsarbeiten.